#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leber's congenital amaurosis Marginal zone lymphoma recurrent Macular telangiectasia Endocrine ophthalmopathy Myelodysplastic syndrome Non-small cell lung cancer metastatic Soft tissue sarcoma Brain abscess Infertility female Lennox-Gastaut syndrome Indolent systemic mastocytosis Breast cancer metastatic Nodal marginal zone B-cell lymphoma Drug eruption Juvenile psoriatic arthritis More trials…

    Learn about Rare Diseases

    Congenital hypotransferrinaemia – Trials in Disease Alveolar rhabdomyosarcoma – Trials in Disease Hereditary hypophosphataemic rickets Marfan’s syndrome – Diagnostics Osteosarcoma metastatic – Diagnostics Alternating hemiplegia of childhood – Life with Disease Prolymphocytic leukaemia Cytokine release syndrome Prader-Willi syndrome Anaplastic thyroid cancer – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cetirizine Dihydrochloride MARALIXIBAT Obefazimod Tioguanine Cefepime Hydrochloride Budesonide GSKVX000000034796 Vericiguat Lixudebart Gadoxetic Acid, Disodium VANADIUM OXIDE SULFATE Sodium Fluoride (18F) Secukinumab Gskvx000000008885 Ranitidine Rugonersen SKB410 RNMB2 Dordaviprone Amy109 More therapies…

    Learn about Your Condition

    Factor IX deficiency Alcoholism Hepatitis D Obliterative bronchiolitis Drug use disorder Intellectual disability Hodgkin's disease refractory Hernia repair Duchenne muscular dystrophy Alport's syndrome Rhabdoid tumour of the kidney Febrile neutropenia Hyperphagia Muscular dystrophy Type 1 diabetes mellitus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cabinet Medical de Diabet, Nutritie si Boli Metabolice-Dr….

Cabinet Medical de Diabet, Nutritie si Boli Metabolice-Dr. Zaharie Daniela Gabriela

Str. Dumbrava, Nr. 43, Bl. D19, Sc. A, Et. Parter, Ap. 3, Zalău, 450112, Romania

Want to learn more about this study or check if you can participate? Contact us.

  • A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Cagrilintide
    • Dapagliflozin
    • Metformin
    Bulgaria Croatia Czechia Denmark Finland Germany +9

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!